HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hua Zhu Selected Research

Adenocarcinoma

1/2022Higher accuracy of [68 Ga]Ga-DOTA-FAPI-04 PET/CT comparing with 2-[18F]FDG PET/CT in clinical staging of NSCLC.
1/2018Current Standards and Recent Advances in Biomarkers of Major Endocrine Tumors.
9/201764Cu-PSMA-617: A novel PSMA-targeted radio-tracer for PET imaging in gastric adenocarcinoma xenografted mice model.
7/2016Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO.
11/2008Growth suppression of MCF-7 cancer cell-derived xenografts in nude mice by caveolin-1.
10/2007Suppression of staurosporine-mediated apoptosis in Hs578T breast cells through inhibition of neutral-sphingomyelinase by caveolin-1.
10/2004Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hua Zhu Research Topics

Disease

188Neoplasms (Cancer)
04/2024 - 05/2002
53Infections
04/2024 - 03/2002
24Inflammation (Inflammations)
04/2024 - 08/2002
21Neoplasm Metastasis (Metastasis)
01/2023 - 09/2009
20Breast Neoplasms (Breast Cancer)
01/2023 - 07/2004
20Alzheimer Disease (Alzheimer's Disease)
01/2021 - 06/2006
17Prostatic Neoplasms (Prostate Cancer)
02/2024 - 09/2014
16Stomach Neoplasms (Stomach Cancer)
12/2023 - 01/2015
14Hepatocellular Carcinoma (Hepatoma)
03/2024 - 01/2012
13Ischemic Stroke
01/2024 - 01/2014
13Wounds and Injuries (Trauma)
12/2022 - 06/2012
12Carcinogenesis
12/2023 - 11/2008
12Hypoxia (Hypoxemia)
01/2022 - 08/2010
12Keratitis
11/2016 - 12/2002
11COVID-19
11/2023 - 11/2020
11Reperfusion Injury
10/2023 - 06/2014
11Ischemia
01/2022 - 06/2010
10Brain Ischemia (Cerebral Ischemia)
05/2024 - 06/2010
10Chickenpox
04/2024 - 07/2010
9Glioma (Gliomas)
04/2024 - 03/2009
9Carcinoma (Carcinomatosis)
12/2023 - 05/2002
9Virus Diseases (Viral Diseases)
11/2021 - 09/2004
8Herpes Zoster
04/2024 - 07/2010
8Lung Neoplasms (Lung Cancer)
12/2023 - 01/2018
8Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2022 - 01/2015
8Insulin Resistance
01/2022 - 10/2009
7Stroke (Strokes)
05/2024 - 09/2014
7Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2015
7Cognitive Dysfunction
10/2022 - 11/2012
7Adenocarcinoma
01/2022 - 10/2004
6Infarction (Infarctions)
01/2024 - 01/2014
6Type 2 Diabetes Mellitus (MODY)
12/2023 - 10/2009
6Sepsis (Septicemia)
06/2023 - 10/2005
6Necrosis
06/2023 - 10/2007
6Adenocarcinoma of Lung
01/2023 - 01/2015
6Fibrosis (Cirrhosis)
01/2022 - 02/2014
6Renal Cell Carcinoma (Grawitz Tumor)
10/2020 - 02/2015
5Cardiotoxicity
12/2023 - 02/2016
5Hemorrhage
04/2022 - 12/2003
5Pneumonia (Pneumonitis)
11/2021 - 01/2015
5Brain Injuries (Brain Injury)
01/2018 - 06/2010
4Mitochondrial Diseases (Mitochondrial Disease)
05/2024 - 12/2017
4Non-alcoholic Fatty Liver Disease
03/2024 - 05/2019
4Body Weight (Weight, Body)
03/2024 - 01/2011

Drug/Important Bio-Agent (IBA)

65Proteins (Proteins, Gene)FDA Link
03/2024 - 03/2002
35Biomarkers (Surrogate Marker)IBA
03/2024 - 07/2005
27VaccinesIBA
04/2024 - 07/2005
21AntigensIBA
10/2023 - 05/2002
16Messenger RNA (mRNA)IBA
08/2022 - 03/2002
15Peptides (Polypeptides)IBA
01/2023 - 09/2014
15MicroRNAs (MicroRNA)IBA
01/2022 - 09/2008
14Long Noncoding RNAIBA
03/2024 - 01/2015
14CytokinesIBA
03/2024 - 08/2002
13Glucose (Dextrose)FDA LinkGeneric
12/2023 - 10/2009
13Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
09/2023 - 01/2011
11Antiviral Agents (Antivirals)IBA
03/2024 - 11/2008
10Therapeutic UsesIBA
04/2024 - 01/2011
10RNA (Ribonucleic Acid)IBA
03/2024 - 01/2010
10Immune Checkpoint InhibitorsIBA
03/2024 - 11/2018
10Radioisotopes (Radionuclides)IBA
01/2024 - 06/2017
9Polysaccharides (Glycans)IBA
04/2024 - 02/2016
9LigandsIBA
11/2023 - 07/2015
81,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2024 - 01/2016
8ChemokinesIBA
01/2022 - 08/2002
7Peptide Hydrolases (Proteases)FDA Link
03/2024 - 12/2002
7InterferonsIBA
03/2024 - 04/2005
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024 - 01/2015
7AntibodiesIBA
12/2022 - 11/2014
7Glycoproteins (Glycoprotein)IBA
01/2022 - 09/2009
6Monoclonal AntibodiesIBA
04/2024 - 12/2014
6Angiotensin-Converting Enzyme 2IBA
11/2023 - 10/2007
61,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2023 - 01/2018
6Immunoglobulin G (IgG)IBA
01/2023 - 05/2002
6Complement System Proteins (Complement)IBA
01/2023 - 08/2010
6CollagenIBA
01/2023 - 02/2014
6Caveolin 1IBA
12/2022 - 07/2004
6DNA (Deoxyribonucleic Acid)IBA
10/2020 - 09/2004
6Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 10/2006
5RadiopharmaceuticalsIBA
04/2024 - 01/2020
5Molecular Probes (Molecular Probe)IBA
01/2024 - 01/2021
5Somatostatin Receptors (Somatostatin Receptor)IBA
10/2023 - 06/2017
5Carrier Proteins (Binding Protein)IBA
02/2023 - 04/2005
5Small Interfering RNA (siRNA)IBA
01/2023 - 01/2010
5Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2023 - 03/2008
5LipidsIBA
01/2023 - 10/2009
5AntioxidantsIBA
10/2022 - 01/2022
5EnzymesIBA
09/2022 - 03/2015
5Trastuzumab (Herceptin)FDA Link
01/2022 - 11/2018
5Sorafenib (BAY 43-9006)FDA Link
01/2022 - 04/2015
5Melanins (Melanin)IBA
01/2021 - 12/2008
5ErbB Receptors (EGF Receptor)IBA
01/2021 - 01/2012
5Insulin (Novolin)FDA Link
06/2016 - 10/2009
4Glutamine (L-Glutamine)FDA Link
03/2024 - 01/2018
4Hematoxylin (Haematoxylon)IBA
12/2023 - 01/2015

Therapy/Procedure

76Therapeutics
04/2024 - 07/2005
21Immunotherapy
04/2024 - 07/2013
16Drug Therapy (Chemotherapy)
01/2024 - 02/2010
11Contact Lenses
01/2019 - 12/2002
5Transplantation
01/2023 - 05/2002
5Radiotherapy
01/2022 - 01/2018